Wells Fargo initiated coverage on Henry Schein with a new price target
$HSIC
Medical Specialities
Health Care
Wells Fargo initiated coverage of Henry Schein with a rating of Equal Weight and set a new price target of $80.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/9/2026 | $85.00 | Market Perform | BMO Capital Markets |
| 6/11/2026 | $100.00 | Neutral → Buy | BTIG Research |
| 4/16/2026 | Neutral | BTIG Research | |
| 4/15/2026 | $100.00 | Buy | Citigroup |
| 2/23/2026 | $100.00 | Neutral → Outperform | Robert W. Baird |
| 12/9/2025 | $86.00 | Overweight | Barclays |
| 8/26/2025 | $83.00 | In-line → Outperform | Evercore ISI |
| 7/25/2025 | $75.00 | Buy → Hold | Stifel |
11-K - HENRY SCHEIN INC (0001000228) (Filer)
SD - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
Henry Schein, Inc. (NASDAQ:HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry Schein website following the presentat
MIAMI, June 30, 2026 /PRNewswire/ -- GoTu Technology, the nation's leading dental talent marketplace, and Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced a new strategic partnership designed to help dental practices address ongoing staffing challenges and maintain continuity of patient care. Through this collaboration between GoTu and Henry Schein Dental Recruitment Services (a division of Henry Schein Financial Enterprises, LLC, a wholly-owned subsidiary of Henry Schein), d
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contributions to the Company. Mr. Daniel joined the Henry Schein Board of Directors in May 2025. He possesses decades of board and global executive leadership experience in healthcare and industrial sectors, including serving for 14
4 - HENRY SCHEIN INC (0001000228) (Issuer)
3 - HENRY SCHEIN INC (0001000228) (Issuer)
4/A - HENRY SCHEIN INC (0001000228) (Issuer)
BMO Capital Markets initiated coverage of Henry Schein with a rating of Market Perform and set a new price target of $85.00
BTIG Research upgraded Henry Schein from Neutral to Buy and set a new price target of $100.00
BTIG Research initiated coverage of Henry Schein with a rating of Neutral
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
Partnership Expands Access to FDA-Cleared CitoCBC® System Across the U.S. Henry Schein, Inc. (NASDAQ:HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115495488/en/CLIA Waived CitoCBC System Des
Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. This press release features multimedia. View the full release here: https://www.businesswire
Mr. Bergman to Continue to Serve as Chairman of the Board Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman will retire as Chief Executive Officer (CEO) at the end of the year after 45 years at the Company, including more than 35 years as CEO. Mr. Bergman will continue to lead Henry Schein in his current role until his retirement and will remain as Chairman thereafter. The Board is commencing a formal search process in conjunction with a nationally recognized executive search firm and will consider internal and external candidates. "With the progress made advan
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
Henry Schein, Inc. (NASDAQ:HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry Schein website following the presentat
Q1 2026 GAAP diluted EPS of $0.92 compared to $0.88 GAAP diluted EPS in Q1 2025 Q1 2026 non-GAAP diluted EPS of $1.32 compared to $1.15 non-GAAP diluted EPS in Q1 2025 Reaffirming guidance for 2026 sales, non-GAAP diluted EPS, and Adjusted EBITDA Confirming that value creation initiatives are expected to deliver over $200 million of operating income improvement over the next few years, with $125 million run-rate by year-end 2026 Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 28, 2026. "I am pleased with our strong first
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2026 financial results before the stock market opens on Tuesday, May 5, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Frederick M. Lowery, Chief Executive Officer and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry Schein website following the prese